Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:06 PM
Ignite Modification Date:
2025-12-24 @ 9:06 PM
NCT ID:
NCT02280304
Eligibility Criteria:
Inclusion Criteria:
* Mild traumatic brain injury (mTBI) as defined by the VA/DoD Clinical Practice Guideline.
* PTSD as assessed by the Clinician Administered PTSD Scale (CAPS);
* Aged 18 - 49;
* Have not previously participated in meditation training.
Exclusion Criteria:
The investigators will exclude subjects who:
* Meet DSM-IV criteria for drug or alcohol abuse in past 30 days;
* Have a history of severe TBI based on any of following:
* Glasgow Coma Score \< 8;
* alteration of consciousness greater than 24 hours; loss of consciousness greater than 30 minutes;
* Have current neurological or general medical conditions known to impact cognitive and/or emotional functioning, including but not limited to:
* epilepsy,
* Parkinson's disease,
* Huntington's disease,
* Alzheimer's disease,
* stroke,
* chemotherapy for cancer;
* Have acute psychological instability as assessed by MEDVAMC clinician or study staff or concurrent diagnosis or schizophrenia, schizoaffective disorder, delusional disorder, organic psychosis, and subjects taking antipsychotic medication, and
* Have already completed a course of meditation training.
* The investigators will also exclude participants with general contraindications for MRI, including metal in or around the head (e.g., orthodontia, non-removable body piercings, etc.), ferromagnetic material in the body (e.g., non-removable body piercings), or non-MRI compatible medical devices.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
49 Years
Study:
NCT02280304
Study Brief:
Protocol Section:
NCT02280304